Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-04-16

Clinical Trial Update: Lactated Ringer's Versus 5% Human Albumin: Cardiac Surgical Patients [Phase 2]

View source ↗

Summary

Phase 2 trial comparing Lactated Ringer's solution to 5% human albumin in cardiac surgical patients was terminated; results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • 5% Human Albumin (human albumin)
  • Lactated Ringer's solution (Ringer's lactate solution)

Snippet

Sponsor: William C. Oliver | Conditions: Hemodynamic Stability | Phase 2 | Status: TERMINATED | Results posted: 2019-04-16